Potent, Plasmodium-Selective Farnesyltransferase Inhibitors That Arrest the Growth of Malaria Parasites: Structure−Activity Relationships of Ethylenediamine-Analogue Scaffolds and Homology Model Validation
Authors:
- Christopher G. CummingsCCChristopher G. Cummings
- Kasey RivasKRKasey Rivas
- William P. KattWKWilliam P. Katt
- Carrie HornéyCHCarrie Hornéy
- Frederick S. BucknerFBFrederick S. Buckner
- Debopam ChakrabartiDCDebopam Chakrabarti
- Saïd M. SebtiSSSaïd M. Sebti
- Michael H. GelbMGMichael H. Gelb
- Wesley C. Van VoorhisWVWesley C. Van Voorhis
- Andrew D. HamiltonAHAndrew D. Hamilton
- 8 August 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (17) , 5176-5197
Abstract
New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel series of antimalarial, ethylenediamine-based inhibitors of protein farnesyltransferase (PFT). In the current study, we designed and synthesized a series of second generation inhibitors, wherein the core ethylenediamine scaffold was varied in order to examine both the homology model of Plasmodium falciparum PFT (PfPFT) and our predicted inhibitor binding mode. We identified several PfPFT inhibitors (PfPFTIs) that are selective for PfPFT versus the mammalian isoform of the enzyme (up to 136-fold selectivity), that inhibit the malarial enzyme with IC50 values down to 1 nM, and that block the growth of P. falciparum in infected whole cells (erythrocytes) with ED50 values down to 55 nM. The structure−activity data for these second generation, ethylenediamine-inspired PFT inhibitors were rationalized by consideration of the X-ray crystal structure of mammalian PFT and the homology model of the malarial enzyme.Keywords
This publication has 32 references indexed in Scilit:
- Efficacy, Pharmacokinetics, and Metabolism of Tetrahydroquinoline Inhibitors of Plasmodium falciparum Protein FarnesyltransferaseAntimicrobial Agents and Chemotherapy, 2007
- Second Generation Tetrahydroquinoline-Based Protein Farnesyltransferase Inhibitors as AntimalarialsJournal of Medicinal Chemistry, 2007
- Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferaseMolecular and Biochemical Parasitology, 2007
- Structurally Simple, Potent, Plasmodium Selective Farnesyltransferase Inhibitors That Arrest the Growth of Malaria ParasitesJournal of Medicinal Chemistry, 2006
- Structurally Simple Farnesyltransferase Inhibitors Arrest the Growth of Malaria ParasitesAngewandte Chemie International Edition, 2005
- Malaria in 2002Nature, 2002
- Medical need, scientific opportunity and the drive for antimalarial drugsNature, 2002
- The economic and social burden of malariaNature, 2002
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Human Malaria Parasites in Continuous CultureScience, 1976